Cambridge Investment Research Advisors, Inc. - MABVAX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of MABVAX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2017$2,141,000
+32.0%
3,058,703
+22.6%
0.02%
+13.6%
Q3 2017$1,622,0002,495,2030.02%
Other shareholders
MABVAX THERAPEUTICS HLDGS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 26,708$61,0000.11%
Delaney Dennis R 10,000$23,0000.05%
WELLS FARGO & COMPANY/MN 3$00.00%
MILLENNIUM MANAGEMENT LLC 20,373$46,0000.00%
DEUTSCHE BANK AG\ 3$00.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 7$00.00%
UBS Group AG 4,957$11,0000.00%
Sargent Bickham Lagudis LLC 2$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1$00.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
View complete list of MABVAX THERAPEUTICS HLDGS IN shareholders